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Norovirus is a major causative pathogen of acute gastroenteritis in humans of all age groups ([@B1]). The virus is classified into genogroups I to VII (GI to GVII) ([@B2]). Patients with gastroenteritis are typically infected by noroviruses GI and GII, which have 9 and 22 genotypes, respectively. Given the emergence of recombinant strains, norovirus experts recommend that genotyping for worldwide surveillance use two proteins: the RNA-dependent RNA polymerase (RdRp) gene in open reading frame 1 (ORF1) and the capsid viral protein 1 (VP1) gene in ORF2 ([@B3]).

A novel recombinant norovirus was detected in the diarrheal feces of nine patients in an outbreak in Kawasaki City, Japan, in 2016. The strain was assigned to GII.P16-GII.4_Sydney2012 by the norovirus genotyping tool ([@B4]). One strain was used for complete genome sequencing. Primers for amplifying the 5′ terminus-ORF1 fragments of GII.P16-GII.4 strain were based on the published sequence of GII.P16 (KJ407074). The fragment of the ORF2-3′ terminus was amplified as described previously ([@B5], [@B6]). The complete genome of the strain was sequenced using primers based on the closely related sequences of GII.P16 (KJ407074) and GII.4_Sydney2012 (AB972482). The 5′-terminal sequence was analyzed using the 5′ Full RACE Core Set (TaKaRa, Shiga, Japan).

Except for its poly(A) tail, the complete genome of GII.P16-GII.4_Sydney2012 was 7,560 bp in length. Its GC compositions were 48.5% and 48.8% in the the 5′ terminus-ORF1 and ORF2-3′ terminus sequences, respectively. The strain had nucleotide sequence identities of 95.1% to the closest Hu/GII/RUS/2012/GII.P16/Smolensk/S12-31 strain (KF895841) in the 5′ terminus-ORF1 and 97.2% to the closest Hu/GII/ITA/2013/GII.4_Sydney2012/PA13 strain (KF378731) in the ORF2-3′ terminus. The recombination breakpoint was predicted to be at nucleotide position 5088, which is in a sequence between ORF1 and ORF2 that is conserved on norovirus genomes ([@B7]).

To our knowledge, this is the first report of a complete genome sequence of norovirus GII.P16-GII.4_Sydney2012. Norovirus infection is caused mostly by the GII.4 genotype, followed by GII.2, GII.3, GII.6, and GII.17 ([@B8][@B9][@B11]). The most prevalent GII.4 contained GII.P4 and GII.Pe RdRp sequences, and GII.P16 strains with various VP1 genotypes have been detected in some countries ([@B12][@B13][@B20]). The amino acid identity was 95 to 100% among GII.P16 RdRp sequences, and these diverged phylogenetically into two clusters. GII.P16 showed an amino acid identity of 88 to 93% to GII.P4 and GII.Pe in the RdRp sequences. Some proteins within ORF1 are associated with the pathogenesis of norovirus ([@B21], [@B22]). Additionally, recent reports have shown that an interaction between the human norovirus GII RdRp and GII VP1 proteins, but not the murine norovirus VP1, enhanced host RIG-I-dependent interferon signaling activity via replicative RNA in a human cell line, whereas the GII VP2 downregulated the innate immune signaling ([@B23], [@B24]). Norovirus GII exhibits genetic diversity among the genotypes in the capsid sequence, which is crucial for host entry and the production of blocking antibodies, and also in the nonstructural polyprotein-coding sequence ([@B25][@B26][@B28]). Therefore, appropriate combinations of ORF1 and ORF2-ORF3 sequences may be associated with the enhancement of norovirus pathogenesis and infectivity, which leads to the prevalence of restricted genotypes.
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The GenBank accession number for the norovirus Hu/GII/JP/2016/GII.P16-GII.4_Sydney2012/Kawasaki194 genome sequence is [LC175468](http://www.ncbi.nlm.nih.gov/nuccore/LC175468).
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